Literature DB >> 34132956

Circ_0072995 Promotes Ovarian Cancer Progression Through Regulating miR-122-5p/SLC1A5 Axis.

Xiaoqing Huang1, Yongjie Luo1, Xuejiao Li2.   

Abstract

Ovarian cancer is a common cancer affecting women with high morbidity and mortality globally. Circular RNAs (circRNAs) have been found play vital roles in multifarious cancers, including OC. This study aims to explore the biological role and underlying mechanism of circ_0072995 in OC progression. Circ_0072995 was upregulated in OC tissues and cells in a stable structure. Functional experiments indicated that circ_0072995 knockdown suppressed cell proliferation, migration, invasion and accelerated cell apoptosis of OC cells. Mechanistically, miR-122-5p was a direct target of circ_0072995, and its knockdown reversed the effects of circ_0072995 silence on inhibition of OC cell progression. Meanwhile, SLC1A5 was a downstream target gene of miR-122-5p, and miR-122-5p overexpression inhibited the progression of OC cells by targeting SLC1A5. Moreover, circ_0072995 positively regulated SLC1A5 expression via sponging miR-122-5p. Circ_0072995 could play oncogenic role in tumorigenesis and malignant development of OC by regulating miR-122-5p/SLC1A5 axis, providing a novel approach for OC treatment.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Circ_0072995; Ovarian cancer; SLC1A5; miR-122-5p

Mesh:

Substances:

Year:  2021        PMID: 34132956     DOI: 10.1007/s10528-021-10092-5

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  8 in total

1.  New Therapies for Ovarian Cancer.

Authors:  David M O'Malley
Journal:  J Natl Compr Canc Netw       Date:  2019-05-01       Impact factor: 11.908

2.  Circular RNA circ-SMAD7 promoted ovarian cancer cell proliferation and metastasis by suppressing KLF6.

Authors:  Y Zhao; X-P Qin; Y-P Lang; D Kou; Z-W Shao
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-07       Impact factor: 3.507

3.  Upregulated SLC1A5 promotes cell growth and survival in colorectal cancer.

Authors:  Fang Huang; Yingchao Zhao; Junzhang Zhao; Shuang Wu; Yao Jiang; Hong Ma; Tao Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

4.  Clinical associations between ASCT2 and p‑mTOR in the pathogenesis and prognosis of epithelial ovarian cancer.

Authors:  Huiming Guo; Yu Xu; Feng Wang; Zongwen Shen; Xiaoyu Tuo; Hong Qian; Huawe Wang; Kunhua Wang
Journal:  Oncol Rep       Date:  2018-09-24       Impact factor: 3.906

Review 5.  Ovarian cancer: an overview.

Authors:  Michelle A Roett; Patricia Evans
Journal:  Am Fam Physician       Date:  2009-09-15       Impact factor: 3.292

6.  MicroRNA-1-3p inhibits the growth and metastasis of ovarian cancer cells by targeting DYNLT3.

Authors:  F-J Zhu; J-Z Li; L-L Wang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-09       Impact factor: 3.507

7.  MicroRNA profiling of plasma exosomes from patients with ovarian cancer using high-throughput sequencing.

Authors:  Honghong Zhang; Sijuan Xu; Xiaoli Liu
Journal:  Oncol Lett       Date:  2019-04-05       Impact factor: 2.967

8.  Comprehensive Analysis of a circRNA-miRNA-mRNA Network to Reveal Potential Inflammation-Related Targets for Gastric Adenocarcinoma.

Authors:  YunXia Liu; YeFeng Xu; Feng Xiao; JianFeng Zhang; YiQing Wang; YongWei Yao; JieWen Yang
Journal:  Mediators Inflamm       Date:  2020-08-01       Impact factor: 4.711

  8 in total
  2 in total

Review 1.  Emerging role of circular RNAs in the pathogenesis of ovarian cancer.

Authors:  Soudeh Ghafouri-Fard; Tayyebeh Khoshbakht; Bashdar Mahmud Hussen; Mohammad Taheri; Majid Samsami
Journal:  Cancer Cell Int       Date:  2022-04-29       Impact factor: 6.429

2.  HSF1 Stimulates Glutamine Transport by Super-Enhancer-Driven lncRNA LINC00857 in Colorectal Cancer.

Authors:  Qi Shen; Rui Wang; Xinling Liu; Ping Song; Mingzhu Zheng; Xiaomin Ren; Jingang Ma; Zhong Lu; Jiaqiu Li
Journal:  Cancers (Basel)       Date:  2022-08-09       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.